Gastric cancer (HER2-positive metastatic) - trastuzumab: comments received from the public through the NICE website

Gastric cancer (HER2-positive metastatic) - trastuzumab: comments received from the public through the NICE website

Gastric cancer (HER2-positive metastatic) - trastuzumab: comments received from the public through the NICE website
29 September 2010
(89.54 Kb 26 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 23 September 2010